Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance

  • Authors:
    • Liansheng Qiu
    • Jiabao Lv
    • Yimin Chen
    • Jiarong Wang
    • Ruishan Wu
  • View Affiliations

  • Published online on: October 12, 2015     https://doi.org/10.3892/ol.2015.3799
  • Pages: 3756-3760
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to determine the effect of S‑phase kinase‑associated protein 2 (Skp2) and cyclin‑dependent kinase inhibitor p27kinase‑interacting protein 1 (p27kip1) protein expression on the occurrence and development of hypopharyngeal squamous cell carcinoma. The protein expression levels of Skp2 and p27kip1 were detected in 42 hypopharyngeal squamous cell carcinoma and 15 normal hypopharyngeal mucous membrane specimens using the an immunohistochemical PV‑9000 two‑step method. The expression levels of Skp2 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (61.90 vs. 26.67%; P<0.05). By contrast, the protein expression levels of Skp2 were significantly positively correlated with tumor T stage (rs=0.329, P<0.05) and cervical lymph node metastasis (rs=0.402, P<0.05). Furthermore, the expression levels of p27kip1 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (11.9 vs. 53.33%; P<0.05), while p27kip1 protein expression was significantly negatively correlated with tumor T‑stage (rs=‑0.351, P<0.05) and cervical lymph node metastasis (rs=‑0.371, P<0.05). Notably, a significant negative correlation was observed between the expression levels of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma (P<0.05). In addition, abnormal expression levels of Skp2 and p27kip1 proteins were observed in hypopharyngeal squamous cell carcinoma tissues. Thus, Skp2 and p27kip1 proteins may be involved in the development of hypopharyngeal squamous cell carcinoma. The current study proposed that combined detection of Skp2 and p27kip1 may be useful for assessing the characteristics and prognosis of hypopharyngeal squamous cell carcinoma.

Introduction

The major features of malignant cancer are uncontrolled cell growth and proliferation, while cell cycle disorder is an important pathogenesis mechanism. The primary function of S-phase kinase-associated protein 2 (Skp2) is its role as the substrate recognition subunit of ubiquitin ligase complex by specific recognition of the phosphorylated substrate, and its ability to mediate ubiquitin ligase complex polyubiquitination and degradation (1,2). Cyclin-dependent kinase (CDK) inhibitor (CKI), p27kinase-interacting protein 1 (p27kip1), is an important negative regulator of the cell cycle (1). As a well-recognized tumor suppressor gene, it is able to control cell cycle transition from G1 to S phase. Thus far, various cell cycle regulators have been identified, including the tumor suppressor p27kip1, p21wafl, cyclin A and p53, all of which may be degraded via the Skp2-mediated ubiquitin-proteasome pathway (2,3). Thus, Skp2 is key in the p27kip1 ubiquitin degradation pathway and may inhibit the proliferation of a variety of cell types through the ubiquitin-proteasome pathway (47). Skp2 and p27kip1 have been to demonstrated to exhibit varying degrees of abnormal expression in a number of solid tumors, including lung cancer (8), oesophageal squamous cell carcinoma and oral squamous cell carcinoma (9,10), laryngeal squamous cell carcinoma (11) and breast cancer (12). They are considered to be closely associated with the occurrence, development and prognosis of malignant tumors (812). The expression levels of Skp2 and p27kip1 proteins have rarely been investigated in hypopharyngeal squamous cell carcinoma. Therefore, the present study used immunohistochemistry to detect the expression of Skp2 and p27kip1 proteins in normal hypopharyngeal mucosa and hypopharyngeal squamous cell carcinoma tissues. The correlation between their expression, and the occurrence and development of hypopharyngeal squamous cell carcinoma, as well as clinical and pathological features, was then analyzed.

Materials and methods

Specimen collection

Hypopharyngeal squamous cell carcinoma specimens (n=42) were obtained from patients treated at the Second Affiliated Hospital of Fujian Medical University (Quanzhou, China) between January 1996 and February 2009. A diagnosis of hypopharyngeal squamous cell carcinoma was confirmed by pathological examination. No patients underwent radiotherapy or chemotherapy prior to the surgery. The 42 cases included 39 males and 3 females, and the median age was 54.8 years. Approval for the present study was obtained from the Ethics Committee of Fujian Medical University. Written informed consent was obtained from all the participants. According to different primary focus of tumors, 21 cases occurred in the piriform sinus, 15 occurred in the posterior wall and 6 in the postcricoid area. According to the differentiation degrees, there were 15 well-differentiated, 17 moderately-differentiated and 10 poorly-differentiated cancer cases. In addition, 37 cases exhibited cervical lymph node metastasis, while 5 cases did not present metastasis. According to the 2002 classification criteria of the Union for International Cancer Control TNM staging system (13), there were 15 T1/T2 stage and 27 T3/T4 stage cases, including T1N0M0 (2 cases), T1N1M0 (1 case), T2N0M0 (2 cases), T2N1M0 (3 cases), T2N2M0 (7 cases),; T3N0M0 (2 cases), T3N1M0 (8 cases), T3N2M0 (9 cases), T4N0M0 (1 case), T4N1M0 (2 cases), T4N2M0 (3 cases) and T4N3M0 (2 cases). Normal hypopharyngeal mucous membranes without cancer cells were identified by observation from the piriform sinus or postcricoid area of specimens obtained during total laryngectomy and used as the control group. Specimens were obtained from 15 patients with laryngeal carcinoma who underwent total laryngectomy at the Second Affiliated Hospital of Fujian Medical University. The specimens were located 3–4 cm from the tumor margin. The patients included 14 males and 1 female, and had an age range of 47–71 years (mean age, 59.1 years). There was no significant difference in age or gender between the control and experimental groups. The normal tissue samples (n=15) were confirmed to be healthy hypopharyngeal mucous membranes by performing a hematoxylin and eosin staining assay.

Immunohistochemical assay

The immunohistochemical assay used a PV-9000 (SP) two-step staining kit (Zhongshan Jinqiao Biotechnology Co., Ltd., Beijing, China), according to the manufacturer's instructions. p27kip1 and Skp2 rat anti-human monoclonal antibodies (1:40 dilutions; catalog nos. ZM-0340 and ZM-0454, respectively), polymer helper and polyperoxidase anti-rat IgG (1:100 dilution) were all purchased from Zhongshan Jinqiao Biotechnology Co., Ltd. Furthermore, breast cancer tissue specimens (ZSGB-BIO Co., Ltd., Beijing, China) were used as the positive control and phosphate-buffered saline (PBS) was used as the negative control.

Analysis of experimental results

To analyze the results of the current study, Skp2 positive cell counts were performed in a minimum of 10 fields per sample under an optical microscope (magnification, ×400; BX51; Olympus Corporation, Tokyo, Japan). In the positive cells counts, ≥100 tumor cells were present in each field. According to a previous study (8), Skp2-positive cells were visualized as brown-yellow particles in the nucleus and negative control cells were normal hypopharyngeal mucous membranes in close proximity to the tumor tissues. Skp2 protein expression was classified as follows: <5% positive cells, (−); 6–25% positive cells, (+); 26–50% positive cells, (++); and >50% positive cells, (+++). Furthermore, >25% positive cells represented a high expression of Skp2. For the expression of p27kip1, positive cells were visualized as brown-yellow particles in the nucleus. p27kip1 protein expression was classified as follows: 0% positive cells, (−); <5% positive cells, (+); 5–50% positive cells, (++); and >50% positive cells, (+++). Furthermore, >50% positive cells represented a high expression of p27kip1. All the results were evaluated by two experienced pathologists using a double-blinded method.

Statistical analysis

Statistical analyses were performed using the SPSS software (version 13.0; SPSS, Inc., Chicago, IL, USA) and data are presented as the mean ± standard deviation. χ2 and Fisher's tests were used to compare data between the groups, while Spearman's rank correlation analysis was used for data correlation. P<0.05 was considered to indicate a statistically significant difference.

Results

Skp2 and p27kip1 protein expression levels

Immunohistochemical staining revealed that Skp2 protein, which was visualized as brown-yellow particles, was predominantly located in the nucleus and rarely located in the cytoplasm (Fig. 1). High Skp2 protein expression was observed in 61.90% (26/42 samples) and 26.67% (4/15 samples) of hypopharyngeal squamous cell carcinoma tissues and normal hypopharyngeal mucous membranes, respectively. Thus, the expression of Skp2 protein was significantly higher in hypopharyngeal squamous cell carcinoma compared with that in normal hypopharyngeal mucous membranes (P<0.05). The expression levels of Skp2 and p27kip1 proteins in normal hypopharyngeal mucosa of the control group were not significantly correlated (χ2=1.26, Pearson coefficient of continency, C=0.2756). p27kip1 protein presented as brown-yellow particles located in the nucleus (Fig. 2). Weak p27kip1 expression was observed in hypopharyngeal squamous cell carcinoma tissues, with only 5 cases exhibiting high expression. In addition, high p27kip1 protein expression was observed in 11.90% (5/42) and 53.33% (8/15) of hypopharyngeal squamous cell carcinoma tissues and normal hypopharyngeal mucous membranes, respectively. This difference was statistically significant (P<0.05; Table I).

Table I.

Comparison of Skp2 and p27kip1 protein expression levels in hypopharyngeal squamous cell carcinoma tissue and normal hypopharyngeal mucous membrane samples.

Table I.

Comparison of Skp2 and p27kip1 protein expression levels in hypopharyngeal squamous cell carcinoma tissue and normal hypopharyngeal mucous membrane samples.

IndexHypopharyngeal squamous cell carcinomaNormal hypopharyngeal mucous membraneP-value
Skp22640.019
p27kip1  580.002

[i] Skp2, S-phase kinase-associated protein 2; p27kip1, p27kinase-interacting protein 1.

Correlation of Skp2 and p27kip1 protein expression levels with clinicopathological characteristics

No statistically significant differences were detected between the age or differentiation degree of patients and the expression of Skp2 protein (P>0.05). However, a significant difference was identified between gender and the expression of Skp2 protein (P<0.05). Despite this significant association, the study population had a 1:13 female: male ratio and the P-value was close to 0.05. Thus, the present authors consider that there may be no significant difference between gender and the expression of Skp2 protein. Notably, there was an significant difference between high expression of Skp2 protein and cervical lymph node metastasis (P<0.01), as well as between T stage and the high expression of Skp2 protein (P<0.05). Spearman's rank correlation analysis indicated that the expression of Skp2 protein was positively correlated with cervical lymph node metastasis [Spearman's correlation coefficient (rs)=0.402, P<0.01] and T staging (rs=0.033, P<0.05) in hypopharyngeal squamous cell carcinoma.

The present study also identified no significant correlation between the gender, age and differentiation degree of patients, and the expression of p27kip1 protein (P>0.05). However, low expression of p27kip1 protein was significantly associated with cervical lymph node metastasis (P<0.01) and T stage (P<0.05). Furthermore, Spearman's rank correlation analysis indicated that the expression of p27kip1 protein was negatively correlated with cervical lymph node metastasis (rs=-0.016, P<0.05) and T stage (rs=-0.351, P<0.05) in hypopharyngeal squamous cell carcinoma (Table II).

Table II.

Association of high Skp2 and p27kip1 protein expression with clinicopathological characteristics in patients with hypopharyngeal squamous cell carcinoma.

Table II.

Association of high Skp2 and p27kip1 protein expression with clinicopathological characteristics in patients with hypopharyngeal squamous cell carcinoma.

Skp2 p27kip1


Pathological characteristicCase, nHigh expression, nP-valueHigh expression, nP-value
Gender
  Male39260.04940.323
  Female  3  0 1
Age, years
  ≥6011  60.72011.000
  <603120 4
Cervical lymph node metastasis
  +37260.00520.008
  –  5  0 3
Primary location of the tumora
  Piriform sinus2112>0.01253>0.0125
  Postcricoid area  6  4 1
  Posterior wall1510 1
T stage
  T1 + T215  60.02940.047
  T3 + T42720 1
Differentiation degree
  High to moderate32180.27030.577
  Low10  8 2

a Calculated using a χ2 test. The expression of Skp2 protein was compared between the piriform sinus and the postcricoid area (P=1.000), the piriform sinus and the posterior wall (P=0.563), and the postcricoid area and the posterior wall (P=1.000). Overall, no statistically significant difference was observed (P>0.0125). In addition, the expression of p27kip1 protein was compared between the piriform sinus and the postcricoid area (P=1.000), the piriform sinus and the posterior wall (P=0.626), and the postcricoid area and the posterior wall (P=0.500). Overall, no statistically significant difference was observed (P>0.0125). Skp2, S-phase kinase-associated protein 2; p27kip1, p27kinase-interacting protein 1.

Correlation analysis between Skp2 and p27kip1 protein expression levels

Spearman's rank correlation analysis indicated that there was a negative correlation between the high expression of Skp2 protein and low expression of p27kip1 protein in hypopharyngeal squamous cell carcinoma (rs=-0.317, P=0.041; Table III).

Table III.

Association between Skp2 and p27kip1 protein expression in hypopharyngeal squamous cell carcinoma.

Table III.

Association between Skp2 and p27kip1 protein expression in hypopharyngeal squamous cell carcinoma.

p27kip1 expression, n

Skp2 expressionHighLowP-valuers
High125
Low4120.041−0.317

[i] Skp2, S-phase kinase-associated protein 2; p27kip1, p27kinase-interacting protein 1; rs, Spearman's correlation coefficient.

Discussion

Skp2 was initially cloned from human fibroblasts in 1995 (13). Skp2 is predominantly located in the S phase of malignant cells and reacts with the cyclin A-CDK complex; thus, it is termed S-phase kinase-associated protein 2. Skp2 behaves as an oncogene in cell systems and is an established protooncogene causally involved in the pathogenesis of lymphomas. Skp2 expression, encoded by the Skp2 gene, appears to be closely correlated with the occurrence and development of carcinomas through binding to various targeting ubiquitinated proteins (2,14). Furthermore, it has been demonstrated that numerous cell cycle proteins exert their effects via a Skp2-dependent ubiquitin proteasome signaling pathway, including cyclin D1, cyclin E, p27kip1 and p53 (2,3). Thus, Skp2 specifically may be involved in the regulation of cell proliferation and apoptosis (15). In addition, Skp2 acts as oncogene through the degradation of p27kip1, with the expression of Skp2 and p27kip1 differing in each stage of the cell cycle. Typically, Skp2 expression initially occurs during the G1-S phase, increases at the S-G2 phase and then quickly decreased at the M phase. A number of previous studies have indicated that p27kip1 is specifically recognized and targeted for ubiquitination by Skp2 (15,16). For instance, Skp2 may recognize the cyclin E-CDK2 and cyclin D-CDK2 complexes, causing phosphorylation of threonine-187 in p27 (15,16). Skp2 is particularly important for regulating the degradation of p27kip1 in the G1-S phase. Disorder of cell cycle regulation is a critical molecular biological event in tumorigenesis; thus, cell cycle regulating factors may be relevant to tumorigenesis. For example, CKIs exhibit negative effects on cell cycle regulation. In particular, p27kip1, which a member of the CKI family functioning as a negative regulating factor of the cell cycle, may play a key role in cell proliferation. Currently, p27kip1 is known as a tumor-suppressing gene (17). A previous study proposed that mutations of the p27 gene are rare in tumors (18); however, abnormal p27 protein expression was observed in the tumors investigated in the present study. This abnormal expression may be the result of low gene transcription or high protein activity. Various tumors, including colon cancer, rectum cancer, cervical carcinoma, oral squamous cell carcinoma, gastric cancer, lung cancer and prostatic cancer, have been found to exhibit a high expression of Skp2 protein but low expression of p27kip1 protein (19,20), and a negative correlation was identified between Skp2 and p27kip1 protein expression (812). Furthermore, tumor malignancy and prognosis were correlated with Skp2 expression (21,22).

In the present study, 26/42 samples (61.9%) exhibited Skp2 protein expression in hypopharyngeal squamous cell carcinoma tissues; however, Skp2 protein expression was low in 11/15 and high in 4/15 of normal hypopharyngeal mucous membranes. In addition, p27kip1 protein expression was observed in 5/42 (11.9%) samples of hypopharyngeal squamous cell carcinoma and high p27kip1 protein expression was observed in 8/15 (53.33%) samples of normal hypopharyngeal mucous membranes. This difference was statistically significance (P<0.05). Spearman's rank correlation analysis identified that overexpression of Skp2 protein was negatively correlated with low expression of p27kip1 protein in hypopharyngeal squamous cell carcinoma tissues (rs=-0.317, P=0.041). The current results were similar to those of previous studies conducted (5,10), and indicate that Skp2 downregulates the expression of p27kip1 through ubiquitination in hypopharyngeal squamous cell carcinoma. Thus, high expression of Skp2 protein and low expression of p27kip1 protein may promote tumor cell progression from G1 to S phase. p27kip1 is unable to effectively inhibit aberrant cell proliferation, but can accelerate cell malignancy (18,21). Therefore, it is proposed that Skp2 promotes the development of hypopharyngeal squamous cell carcinoma through degradation of p27kip1 protein.

In numerous malignant tumors, including gastric (8), breast (12), prostate (18) and colon cancer (8), increased Skp2 protein expression is observed concurrently with reduced p27kip1 protein expression. Increased Skp2 protein expression indicates a poorer prognosis and more highly-differentiated tumors. Furthermore, p27kip1 appears to be involved in regulating cell differentiation and intercellular adhesion, which are processes associated with tumor infiltration and metastasis, respectively. This may be due to lack of p27kip1 transcription or decreased p27kip1 protein expression causing inhibition of the cell proliferation, disorder of the cell cycle and low cell differentiation. Furthermore, p27kip1 regulates intercellular adhesion by aggregating N-cadherin to prevent normal cells from binding to stroma or receiving extracellular signals (8,9,12,17,18). In a previous study, p27kip1 protein expression caused a reduction in tumor cell adhesion and tumor metastasis (17). The current results demonstrated that high expression of Skp2 protein and low expression of p27kip1 protein were significantly associated with cervical lymph node metastasis and T-stage in 42 samples of hypopharyngeal squamous cell carcinomas. Furthermore, correlation analysis identified a positive correlation between high expression of Skp2 protein, and cervical lymph node metastasis and T-stage, and a negative correlation between low expression of p27kip1 protein, and cervical lymph node metastasis and T-stage. By contrast, the expression levels of Skp2 and p27kip1 protein were not significantly associated with age, gender or differentiation degree (P>0.05). The aforementioned results were similar to those obtained in the present study, which indicated that high expression of Skp2 protein and low expression of p27kip1 protein may aid in predicting the degree of tumor infiltration and cervical lymph node metastasis in hypopharyngeal squamous cell carcinoma. Furthermore, these two proteins may be useful for assessing the biological characteristics of hypopharyngeal squamous cell carcinoma.

However, Dowen et al (23) opposed the aforementioned theory that increased Skp2 protein expression decreases the expression of p27kip1 protein. Instead, the authors proposed that the significance of high Skp2 protein expression in tumors was associated with the degradation of p27kip1 protein, as well as other mechanisms, which may require further investigation.

In conclusion, Skp2 may degrade p27kip1 protein through the ubiquitin-proteasome pathway, thus, participating in the occurrence and development of hypopharyngeal squamous cell carcinoma. Furthermore, the abnormal protein expressions Skp2 and p27kip1 appear to be associated with the poor prognosis of hypopharyngeal squamous cell carcinoma. Therefore, combined detection of Skp2 and p27kip1 may provide significant guidance for comprehensively determining the malignant degree and prognosis of patients with hypopharyngeal squamous cell carcinoma.

References

1 

Slingerland J and Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 183:10–17. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Inuzuka H, Gao D, Finley LW, et al: Acetylation-dependent regulation of Skp2 function. Cell. 150:179–193. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Ezoe S, Matsumura I, Nakata S, et al: GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood. 100:3512–3520. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Sicari BM, Troxell R, Salim F, Tanwir M, Takane KK and Fiaschi-Taesch N: c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein. Endocrinology. 153:861–872. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Dai DM and Zhu H: Expression of P27kip1 and Skp2 in basal cell carcinoma and its clinical pathological characters. Int Oncol. 38:158–160. 2011.

6 

Suzuki S, Fukasawa H, Misaki T, et al: The amelioration of renal damage in Skp2-deficient mice canceled by p27kipl deficiency in Skp2-/-p27/-mice. PLoS One. 7:e362492012. View Article : Google Scholar : PubMed/NCBI

7 

Nakayama K, Nagahama H, Minamishima YA, et al: Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1) polyploidy and centrosome overduplication. EMBO J. 19:2069–2081. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA. 98:5043–5048. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I and Takata T: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 61:7044–7047. 2001.PubMed/NCBI

10 

Shintani S, Li C, Mihara M, Hino S, Nakashiro K and Hamakawa H: Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology. 65:355–362. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Dong Y, Sui L, Watanabe Y, Sugimoto K and Tokuda M: S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Oncol Rep. 10:321–325. 2003.PubMed/NCBI

12 

Signoretti S, Di Marcotullio L, Richardson A, et al: Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 110:633–641. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Patel SG and Shah JP: TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 55:242–258; quiz 261–262, 264. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Zhang H, Kobayashi R, Galaktionov K and Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 82:915–925. 1995. View Article : Google Scholar : PubMed/NCBI

15 

Carrano AC, Eytan E, Hershko A and Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1:193–199. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Yokoi S, Yasui K, Saito-Ohara F, et al: A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol. 161:207–216. 2002. View Article : Google Scholar : PubMed/NCBI

17 

Coats S, Flanagan WM, Nourse J and Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877–880. 1996. View Article : Google Scholar : PubMed/NCBI

18 

Nakatsuka S, Liu A, Yao M, et al: Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. Int J Oncol. 22:561–568. 2003.PubMed/NCBI

19 

Ewald JA and Jarrard DF: Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Transl Oncol. 5:278–287. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Rose AE, Wang G, Hanniford D, et al: Clinical relevance of SKP2 alterations in metastatic melanoma. Pigment Cell Melanoma Res. 24:197–206. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Baresova P, Pitha PM and Lubyova B: Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem. 287:16199–16208. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Tschen SI, Georgia S, Dhawan S and Bhushan A: Skp2 is required for incretin hormone-mediated β-cell proliferation. Mol Endocrinol. 25:2134–2143. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Dowen SE, Scott A, Mukherjee G and Stanley MA: Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer. 105:326–330. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

December-2015
Volume 10 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qiu L, Lv J, Chen Y, Wang J and Wu R: Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance. Oncol Lett 10: 3756-3760, 2015
APA
Qiu, L., Lv, J., Chen, Y., Wang, J., & Wu, R. (2015). Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance. Oncology Letters, 10, 3756-3760. https://doi.org/10.3892/ol.2015.3799
MLA
Qiu, L., Lv, J., Chen, Y., Wang, J., Wu, R."Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance". Oncology Letters 10.6 (2015): 3756-3760.
Chicago
Qiu, L., Lv, J., Chen, Y., Wang, J., Wu, R."Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance". Oncology Letters 10, no. 6 (2015): 3756-3760. https://doi.org/10.3892/ol.2015.3799